News
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
After turning down several new drugs and restricting use of another, Dr. Vinay Prasad drew the ire of the right-wing ...
Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results